Comparison of Epidemiological, Clinical, and Biological Features of Invasive Aspergillosis in Neutropenic and Nonneutropenic Patients: A 6‐Year Survey
Abstract
BACKGROUND: Invasive aspergillosis is an opportunistic infection that occurs mainly among patients with prolonged neutropenia. Few data are available on invasive aspergillosis in nonneutropenic patients. METHODS: The aim of this survey was to compare neutropenic and nonneutropenic patients who had received a diagnosis of invasive aspergillosis at our institution during a 6-year period. RESULTS: Among the 88 cases of invasive aspergillosis analyzed here, 12 were histologically proven, 52 were probable, and 24 were possible. Forty-seven percent of cases were diagnosed in the intensive care unit, and 40% were diagnosed in hematology units. Neutropenia was a risk factor for 52 patients (59%), most of whom had hematological or solid malignancies. Among the 36 nonneutropenic patients (41%), the main underlying conditions were steroid-treated chronic obstructive pulmonary disease, asthma, rheumatoid arthritis, giant-cell arteritis, and microvascular disorders; 10 patients were recipients of solid-organ transplants, and 1 patient was seropositive for human immunodeficiency virus. The distribution of proven and probable invasive aspergillosis was similar for neutropenic and nonneutropenic patients. The mortality rate was 71.5% overall and was significantly higher among nonneutropenic patients than among neutropenic patients (89% vs. 60%; P<.05). Compared with neutropenic patients, nonneutropenic patients were significantly less likely to have symptoms of invasive aspergillosis and more likely to have frequent intercurrent pneumonia due to another microorganism. The sensitivity of mycological examination of bronchoalveolar lavage fluid specimens was higher for nonneutropenic patients than for neutropenic patients (85% vs. 58%; P<.05), whereas the sensitivity of antigenemia was the same for the 2 populations (65% vs. 64%). Findings on thoracic computed tomographs were similar, except that segmental areas of consolidation occurred more frequently among neutropenic patients. CONCLUSION: This survey at a whole institution underlines the high number of cases of invasive aspergillosis among nonneutropenic patients, with an overall mortality rate that was significantly higher than that for neutropenic patients.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The nonangioinvasive form of IPA has been increasingly recognized in a wide range of nonneutropenic hosts.
“The nonangioinvasive form of IPA has been increasingly recognized in a wide range of nonneutropenic hosts (89, 90).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [89]
The citation lists haven’t been fetched yet
References 35 · Cited by 361
- Authors
- Cornillet, A., Camus, C., Nimubona, S., Gandemer, V., Tattevin, P., Belleguic, C., Chevrier, S., Meunier, C., Lebert, C., Aupee, M., Caulet‐Maugendre, S., Faucheux, M., Lelong, B., Leray, E., Guiguen, C., & Gangneux, J. ‐.
- Affiliations
- Hôpital Pontchaillou (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- Institut de Recherche pour le Développement (FR)
- Université de Rennes (FR)
- Corresponding author
- Gangneux, J.‐P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09
- Volume
- 43
- Issue
- 5
- Pages
- 577-584
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2161510674
- Cited by
- 361
- References
- 35
- Citations by year
- 2026: 10 · 2025: 25 · 2024: 11 · 2023: 16 · 2022: 15 · 2021: 15 · 2020: 15 · 2019: 24 · 2018: 14 · 2017: 17 · 2016: 14 · 2015: 17 · 2014: 27 · 2013: 21 · 2012: 17
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- invasive aspergillosis, neutropenia, non-neutropenic patients, risk factors, mortality, bronchoalveolar lavage, antigenemia, solid organ transplant recipients, chronic obstructive pulmonary disease, hematologic malignancies, opportunistic fungal infection, diagnostic sensitivity, intensive care unit, hematology unit
- MeSH terms
- Adolescent, Adult, Aged, Antibodies, Fungal, Antifungal Agents, Antigens, Fungal, Aspergillosis, Child, Child, Preschool, Female, Humans, Male, Middle Aged, Neutropenia, Risk Factors, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review